All stock lists
Biolife Solutions Inc (NASDAQ:BLFS)
US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
38.61+0.00 (+0.00%)
Insider Score
––Not scored
BLFS Insider Score
Insiders here have filed 23 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
BLFS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 28.47 M | 27.50 M | 18.79 M | 28.07 M | 25.42 M | 23.94 M |
| Revenue Growth (YoY) | 11.98 % | 14.87 % | 648.63 % | -8.19 % | 28.94 % | 29.88 % |
| Cost of Revenue | 10.18 M | 10.09 M | 6.11 M | 10.15 M | 8.99 M | 8.15 M |
| Gross Profit | 18.29 M | 17.41 M | 12.68 M | 17.92 M | 16.43 M | 15.79 M |
| SG&A Expense | 13.48 M | 14.73 M | 12.54 M | 14.60 M | 14.13 M | 14.10 M |
| R&D Expense | 2.96 M | 2.65 M | 66.00 K | 2.71 M | 2.72 M | 2.20 M |
| Operating Expenses | 16.59 M | 17.38 M | 6.86 M | 18.01 M | 33.08 M | 17.00 M |
| Operating Income | 1.70 M | 27.00 K | 5.82 M | -89.00 K | -16.64 M | -1.22 M |
| Pretax Income | 2.75 M | 1.25 M | 3.36 M | 703.00 K | -15.71 M | -434.00 K |
| Tax Provision | -42.35 M | 62.00 K | -173.00 K | 82.00 K | 126.00 K | 14.00 K |
| Net Income | 45.10 M | 1.19 M | 3.54 M | 621.00 K | -15.84 M | -448.00 K |
| EPS (Basic) | 0.92 | 0.02 | 0.08 | 0.01 | -0.33 | -0.01 |
| EPS (Diluted) | 0.91 | 0.02 | 0.08 | 0.01 | -0.33 | -0.01 |
| Shares Outstanding | 48.87 M | 48.46 M | 47.75 M | 47.93 M | 47.80 M | 47.13 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.